James C McPartland Selected Research

Biomarkers (Surrogate Marker)

11/2023	The Selective Social Attention task in children with autism spectrum disorder: Results from the Autism Biomarkers Consortium for Clinical Trials (ABC-CT) feasibility study.
4/2023	A functional model for studying common trends across trial time in eye tracking experiments.
1/2023	Evaluation of clinical assessments of social abilities for use in autism clinical trials by the autism biomarkers consortium for clinical trials.
1/2023	Concomitant medication use in children with autism spectrum disorder: Data from the Autism Biomarkers Consortium for Clinical Trials.
1/2023	The Autism Biomarkers Consortium for Clinical Trials: Initial Evaluation of a Battery of Candidate EEG Biomarkers.
1/2022	The autism biomarkers consortium for clinical trials: evaluation of a battery of candidate eye-tracking biomarkers for use in autism clinical trials.
1/2022	Identifying Age Based Maturation in the ERP Response to Faces in Children With Autism: Implications for Developing Biomarkers for Use in Clinical Trials.
1/2021	Brief Report: Preliminary Evidence of the N170 as a Biomarker of Response to Treatment in Autism Spectrum Disorder.
1/2021	Resting state EEG in youth with ASD: age, sex, and relation to phenotype.
1/2020	Day-to-Day Test-Retest Reliability of EEG Profiles in Children With Autism Spectrum Disorder and Typical Development.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

James C McPartland Research Topics

Disease

12	Autism Spectrum Disorder 11/2023 - 02/2012
11	Autistic Disorder (Autism) 11/2023 - 01/2020
2	Neurodevelopmental Disorders 01/2020 - 04/2016
1	Communication Disorders (Communication Disorder) 01/2018
1	Learning Disabilities (Learning Disability) 01/2015
1	Craniosynostoses (Craniosynostosis) 01/2015
1	Language Development Disorders (Semantic-Pragmatic Disorder) 01/2015

Drug/Important Bio-Agent (IBA)

17	Biomarkers (Surrogate Marker)IBA 11/2023 - 02/2012
1	4-O-carboxymethylascochlorinIBA 01/2015

Therapy/Procedure

2	Transcranial Magnetic Stimulation 12/2021 - 01/2019
1	Polypharmacy 01/2023
1	Sutures (Suture) 01/2015